Provided by Tiger Fintech (Singapore) Pte. Ltd.

Caladrius Biosciences

0.4264
0.0000
Volume:- -
Turnover:14.19M
Market Cap:1.72M
PE:- -
High:0.4264
Open:0.4264
Low:0.4264
Close:0.4264
Loading ...
Aug 15, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Aug 10, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Aug 05, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 06, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 09, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
May 23, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Apr 27, 2022

Major Issues Report

8-K - Current report
Apr 21, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2022

Major Issues Report

8-K - Current report
Mar 22, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2022

Major Issues Report

8-K - Current report
Feb 18, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals